Immix Biopharma, Inc. (NASDAQ:IMMX – Free Report) – Stock analysts at Lifesci Capital issued their Q2 2026 earnings per share (EPS) estimates for shares of Immix Biopharma in a research note issued to investors on Wednesday, June 17th. Lifesci Capital analyst P. Dolezal anticipates that the company will earn ($0.15) per share for the quarter. […]